• GT = Genotype; CP = Child-Pugh
HCV cure rates for Harvoni ± ribavirin
GT No cirrhosis or CP A CP B/C
1 > 90% > 85%
4 > 90% N/A
5 > 90% N/A
6 > 90% N/A




Reference [1]
Side effect Harvoni™
12 weeks
N=539
Harvoni™
24 weeks
N=326
Fatigue 13% 18%
Headache 14% 17%
Nausea 7% 9%
Diarrhea 3% 7%
Insomnia 5% 6%
Bilirubin elevations
(> 1.5 X ULN)
< 1% 2%
Lipase elevations
(> 3 X ULN)
2% 3%